Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Apostolopoulos, D. J., Kaspiri A., Spyridonidis T., Patsouras N., Savvopoulos C. A., Davlouros P., et al. (2015).  Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study.. Ann Nucl Med. 29(7), 588-602.
Apostolopoulos, D. J., Gąsowska M., Savvopoulos C. A., Skouras T., Spyridonidis T., Andrejczuk A., et al. (2015).  The impact of transmission-emission misregistration on the interpretation of SPET/CT myocardial perfusion studies and the value of misregistration correction.. Hell J Nucl Med. 18(2), 114-21.
Apostolidis, A., Kirana P-S., Chiu G., Link C., Tsiouprou M., & Hatzichristou D. (2009).  Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients' profile and expectations study.. Eur Urol. 56(6), 937-47.
Apostolidis, S. A., Michalopoulos A. A., Hytiroglou P., Papadopoulos B. N., Fachantidis E. P., Basdanis G. A., et al. (2000).  Prevention of blood-transfusion-induced impairment of anastomotic healing by leucocyte depletion in rats.. Eur J Surg. 166(7), 562-7.
Apostolidis, A., Rantell A., Anding R., Kirschner-Hermanns R., & Cardozo L. (2017).  How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2.. Neurourol Urodyn. 36(4), 869-875.
Apostolidis, A., Rahnama'i M. S., Fry C., Dmochowski R., & Sahai A. (2016).  Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.. Neurourol Urodyn. 35(2), 293-8.
Apostolidis, A. (2015).  Words of wisdom. Re: Intrathecal administration of botulinum toxin type a improves urinary bladder function and reduces pain in rats with cystitis.. Eur Urol. 67(4), 816.
Apostolidis, A. (2019).  Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?. World J Urol. 37(12), 2811-2812.
Apostolidis, N., Bogdanis G. C., Kostopoulos N., Souglis A., & Papadopoulos C. (2014).  Changes in the lipid profile of elite basketball and soccer players after a match.. Res Sports Med. 22(1), 100-10.
Apostolidis, A., Wagg A., A'i M. S. Rahnam, Panicker J. N., Vrijens D., & von Gontard A. (2018).  Is there "brain OAB" and how can we recognize it? International Consultation on Incontinence-Research Society (ICI-RS) 2017.. Neurourol Urodyn. 37(S4), S38-S45.
Apostolidis, A., & Cameron A. P. (2020).  Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA Injections.. Eur Urol Focus. 6(5), 814-816.
Apostolidis, S., Papavramidis T. S., Zatagias A., Michalopoulos A., Papadopoulos V. N., Paramythiotis D., et al. (2008).  Hematemesis, a very rare presentation of solid pseudo-papillary tumors of the pancreas: a case report.. J Med Case Rep. 2, 271.
Apostolidis, A. (2017).  Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?. BJU Int. 120(4), 459-460.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for overactive bladder; how to minimize complications and manage failures.. Curr Drug Targets.
Apostolidis, A. (2013).  Male lower urinary tract symptoms: a riddle waiting to be solved.. Eur Urol. 64(3), 408-10.
Apostolidis, A., Papaefstathiou E., & Gatsos S. (2020).  Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures. Current Drug Targets. 21(15), 1527 - 1536.
Apostolidis, A. (2015).  Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?. Curr Drug Targets. 16(11), 1187-97.
Apostolidis, A., Thompson C., Yan X., & Mourad S. (2013).  An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity.. World J Urol. 31(6), 1469-74.
Apostolidis, S., Michalopoulos A., Papavramidis T. S., Papadopoulos V. N., Paramythiotis D., & Harlaftis N. (2009).  Inguinal endometriosis: three cases and literature review.. South Med J. 102(2), 206-7.
Apostolidis, A., Averbeck M. Augusto, Sahai A., Rahnama'i M. Sajjad, Anding R., Robinson D., et al. (2017).  Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).. Neurourol Urodyn. 36(4), 882-893.
Apostolidis, S., Zatagias A., & Zevgaridis A. (2011).  Intramural gallstones mimicking typical lithiasic cholecystitis.. South Med J. 104(1), 59-60.
Apostolidis, S., Papavramidis T. S., Michalopoulos A., Papadopoulos V. N., Paramythiotis D., & Harlaftis N. (2008).  Groin swelling, the anatomic way out of abdominal haematomas: a case report and explicative literature review.. Acta Chir Belg. 108(2), 251-3.
Apostolidis, S. A., Michalopoulos A. A., Papadopoulos V. N., Paramythiotis D., Zatagias A., Gigis P., et al. (2004).  Effect of ranitidine on healing of normal and transfusion-suppressed experimental anastomoses.. Tech Coloproctol. 8 Suppl 1, s104-7.
Apalla, Z., Lallas A., Karteridou A., Sotiriou E., Papaioannou K., & Chaidemenos G. (2013).  Pyoderma gangrenosum complicating mammaplasty.. Int Wound J. 10(2), 237-8.
APALLA, Z., Karakatsanis G., Papageorgiou M., Kastoridou C., & Chaidemenos G. (2009).  A case of atrophoderma vermiculatum responding to systemic isotretinoin.. J Dermatol Case Rep. 3(4), 62-3.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.